We conducted a pragmatic , randomized , unblinded , multicenter , parallel-group clinical trial ( the Standard and New Antiepileptic Drugs [ SANAD ] trial ) comparing clinical and cost effectiveness of initiating treatment with carbamazepine versus lamotrigine , gabapentin , oxcarbazepine and topiramate , and valproate versus lamotrigine and topiramate .